Facial rejuvenation using photodynamic therapy with a novel preparation of ALA and hyaluronic acid in young adults.
Administration, Cutaneous
Adult
Aminolevulinic Acid
/ administration & dosage
Cosmetic Techniques
Drug Combinations
Face
Female
Gels
Humans
Hyaluronic Acid
/ administration & dosage
Light
Male
Photochemotherapy
/ methods
Photography
Photosensitizing Agents
/ administration & dosage
Pilot Projects
Rejuvenation
Skin
/ diagnostic imaging
Skin Aging
/ drug effects
Treatment Outcome
Facial rejuvenation
Hyaluronic acid
Photodynamic therapy
Journal
Archives of dermatological research
ISSN: 1432-069X
Titre abrégé: Arch Dermatol Res
Pays: Germany
ID NLM: 8000462
Informations de publication
Date de publication:
Oct 2020
Oct 2020
Historique:
received:
10
12
2019
accepted:
18
01
2020
pubmed:
16
2
2020
medline:
18
5
2021
entrez:
16
2
2020
Statut:
ppublish
Résumé
Photodynamic therapy (PDT) is a well-established, non-invasive treatment modality that has shown desirable effects such as improvement of fine lines, dyspigmentation, and other signs of photodamage. Many patients seek to decrease, or reverse, effects of sun damage on the skin. Hyaluronic acid (HA), a naturally occurring glycosaminoglycan found in the body, has enormous potential to bind water which allows the skin to retain moisture and maintain elasticity. Topical application of HA has been found to produce anti-wrinkle effects. We conducted a pilot case series evaluating the safety and efficacy of a commercially available 2% 5-aminolevulinic acid (ALA) gel with hyaluronic acid (ALA-HA) and light-emitting diode-red light (LED-RL) for facial rejuvenation as determined by clinical assessments and digital skin analysis of rhytides, pore size, and erythema. All patients noted improvement of their skin and experienced minimal pain during PDT. Evaluation by dermatologists demonstrated significant improvement in overall skin appearance. Digital analysis of photographs revealed improvement of skin spots, wrinkles, pores, texture, UV spots, brown spots, red areas, and porphyrins. Our findings demonstrated safety and efficacy of this novel preparation of photodynamic gel with HA and subsequent activation with LED-RL.
Identifiants
pubmed: 32060617
doi: 10.1007/s00403-020-02038-5
pii: 10.1007/s00403-020-02038-5
pmc: PMC7429523
doi:
Substances chimiques
Drug Combinations
0
Gels
0
Photosensitizing Agents
0
Aminolevulinic Acid
88755TAZ87
Hyaluronic Acid
9004-61-9
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
567-573Références
Cutis. 2002 Jun;69(6 Suppl):8-13
pubmed: 12095068
Br J Dermatol. 2012 Jul;167(1):150-9
pubmed: 22329784
Lasers Surg Med. 2007 Mar;39(3):203-9
pubmed: 17311325
Arch Dermatol. 2002 Nov;138(11):1462-70
pubmed: 12437452
Dermatol Surg. 2016 Jan;42(1):21-30
pubmed: 26713598
J Drugs Dermatol. 2008 Jul;7(7):633-7
pubmed: 18664154
Photodiagnosis Photodyn Ther. 2017 Sep;19:308-344
pubmed: 28716738
J Drugs Dermatol. 2011 Sep;10(9):990-1000
pubmed: 22052267
J Eur Acad Dermatol Venereol. 2011 Jan;25(1):49-58
pubmed: 20456545
Cell Transplant. 2018 May;27(5):729-738
pubmed: 29692196
J Am Acad Dermatol. 2010 Jan;62(1):85-95
pubmed: 19926165
J Cosmet Laser Ther. 2005 Dec;7(3-4):159-62
pubmed: 16414903
Lasers Med Sci. 2007 Mar;22(1):1-3
pubmed: 17333456
Br J Dermatol. 2006 Nov;155(5):1029-36
pubmed: 17034536
Dermatol Surg. 2016 Jul;42(7):804-27
pubmed: 27336945
Photodiagnosis Photodyn Ther. 2014 Dec;11(4):498-509
pubmed: 25461963
Photodermatol Photoimmunol Photomed. 2011 Dec;27(6):334-5
pubmed: 22092740
Photodiagnosis Photodyn Ther. 2014 Jun;11(2):118-21
pubmed: 24568890
Br J Dermatol. 2009 Sep;161(3):647-53
pubmed: 19519826
Arch Dermatol. 2004 Jan;140(1):33-40
pubmed: 14732657
Dermatol Surg. 2010;36(1):39-48
pubmed: 20002646
J Dermatolog Treat. 2015 Jun;26(3):246-51
pubmed: 24913131
Br J Dermatol. 2017 Sep;177(3):656-665
pubmed: 28122416
J Neurosci. 2016 May 11;36(19):5264-78
pubmed: 27170124